Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From january 15 to february 28, 1979
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
no guideline followed
Principles of method if other than guideline:
1000 mg/kg/day of the substance where administrated daily (5 times a week) by gavage over a period of 30 days to male and female rats.
GLP compliance:
Limit test:

Test material

Constituent 1
Reference substance name:
Direct red 23
Direct red 23
Test material form:
solid: particulate/powder

Test animals

other: Tif: RAIf (SPF)
Details on test animals or test system and environmental conditions:
- Age at study initiation: 4 weeks
- Weight at study initiation: 128-129 g, female; 113-115 g males
- Housing: the animals were housed individually in Macrolon cages type 3 with standardized granulated soft wood bedding (Socicté Parisicnne des sciures Pantin).
- Diet: Pelleted standard diet (Nafag. No. /890) ad Libitum

Neither insecticides nor chemicals were applied in the animal room with the exceptic of a desinfectant: Fungitex SB (Prod. Nr. 30071, Ciba-Geigy).

- Temperature (°C): 22 ± 1°C
- Humidity (%): 55 ± 5%
- Air changes (per hr): 15-17
- Photoperiod (hrs dark / hrs light): 10/10

Administration / exposure

Route of administration:
oral: gavage
Details on oral exposure:
Volume: 10 ml/kg of a daily prepared suspension (10 % compound in Carboxymethyl-cellulose 2 %)
The animals of group 1 (Control) received a similar treatment with CMC 2 % without the compound.
Duration of treatment / exposure:
4 weeks and 2 days of the 5th week (30 days)
Frequency of treatment:
5 times at week (in total 22 doses); 1 dose per day for 4 weeks plus in the 5th week on Monday to Tuesday
Doses / concentrations
Doses / Concentrations:
no data
No. of animals per sex per dose:
20 males, 20 females per experimental group
Control animals:
yes, concurrent vehicle


Observations and examinations performed and frequency:
MORTALITY: Yes, daily

SYMPTOMS: Yes, daily

BODY WEIGHT: Yes, weekly


EYE EXAMINATION: Yes, by observation prior to dosing and after the treatment period

HEARING TEST: prior to dosing and after the treatment period (by hand clapping)

MEAN FOOD CONSERVATION: was calculated according the following formula: MFC = (weekly food consumption in g / midweek body weight) x (1000/7)

Haematologic, blood chemistry and urinalysis measurements were carried out by standard methods on 20 randomized rats (5 males, 5 females per group) from the control and one test group at test day 28.
To reduce the biologic variability due to circadian rhythms, blood sampling for haematology and blood chemistry was between the hours of 8.00 and 9.00 a.m. For blood chemistry measurements food was withheld overnight prior to blood removal. The site of blood removal was the orbital sinus and a micro-
haematocrit glass capillary tube was used.
Blood samples from each animal with the respective anticoagulant (EDTA for performing haematologleal and heparin for blood chemistr measurements) were aliquoted into individual vials.
No anaesthesia was used to restrain the animals. All blood collection was by manual restraint only.
Urine for analysis was collected overnight. The individual rats were housed in special metabolism cages.
Food and water was withheld during the time of urine collection.
The quantitative assay of all blood parameters was completed within a 8 h. period under "Quality Control" conditions.
For each time point and parameter a uni-variate statistical analysis was conducted. Due to the routine manner of the analysis system parameter free methods were applied. The treated group was compared to the control group in respect of dispersion and displacement.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
Comparable to the controls
Food efficiency:
no effects observed
Description (incidence and severity):
Comparable to the controls
Haematological findings:
no effects observed
Description (incidence and severity):
Clinical biochemistry findings:
no effects observed
Description (incidence and severity):
Unremarkable and comparable to those of the controls
Urinalysis findings:
no effects observed
Description (incidence and severity):
Organ weight findings including organ / body weight ratios:
no effects observed
Description (incidence and severity):
No statistically significant
Details on results:
During the experiment no treatment realted reactions were observed with respect to clinical symptoms, mortality, food consumption, body weight, clinacl laboratory investigations and pathology.
Eye examination did not reveal any ocular changes. No loss hearing ability was registred.

At the end of the 30 day toxicity study or after an additional recovery period of two weeks the treated rats showed neither macroscopical nor microscepical changes which could be related to the treatment with FAT 11 11o/N.

Effect levels

Dose descriptor:
Effect level:
> 1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Basis for effect level:
clinical signs

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Macroscopical Findings:

All details regarding the gross anatomical changes are listed within the macroscopical findings in individual rats. No compound related gross anatomical changes were noted.

Microscopical Findings:

All details regarding the histopathological changes are listed within the microscopical findings in individual rats. All minor changes seen in some control and treated rats and described within the microscopical findings in individual rats were only incidental in nature and not related to the treatment with FAT 11 110/N.

Applicant's summary and conclusion

It can be concluded from the observations made during the study that 1000 mg/kg/day of FAT 11'110/N produced no observable effects in male and female rats when administrated daily by gavage over a period of 30 days.
Executive summary:

The toxicity of FAT 11'110/N was investigated during a period over 30 day on females and males rats by oral administration.

No observable effects were observed at a dosage of 1000 mg/kg/day.